Universe Pharmaceuticals (UPC) Total Debt: 2020-2024
- Universe Pharmaceuticals' Total Debt rose 45.81% to $8.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $26.5 million, marking a year-over-year increase of 85.25%. This contributed to the annual value of $8.0 million for FY2024, which is 45.81% up from last year.
- Universe Pharmaceuticals' Total Debt amounted to $8.0 million in Q3 2024, which was up 5.29% from $7.6 million recorded in Q1 2024.
- Universe Pharmaceuticals' 5-year Total Debt high stood at $956.5 billion for Q3 2020, and its period low was $7,293 during Q1 2022.
- Moreover, its 3-year median value for Total Debt was $5.5 million (2023), whereas its average is $5.0 million.
- Per our database at Business Quant, Universe Pharmaceuticals' Total Debt slumped by 100.00% in 2021 and then spiked by 74,528.34% in 2023.
- Universe Pharmaceuticals' Total Debt (Quarterly) stood at $956.5 billion in 2020, then crashed by 100.00% to $19,723 in 2021, then skyrocketed by 17,033.62% to $3.4 million in 2022, then surged by 62.24% to $5.5 million in 2023, then skyrocketed by 45.81% to $8.0 million in 2024.
- Its Total Debt was $8.0 million in Q3 2024, compared to $7.6 million in Q1 2024 and $5.5 million in Q3 2023.
